Eton Pharmaceuticals Stock Market Value
| ETON Stock | USD 11.23 0.48 4.47% |
| Symbol | Eton |
Eton Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eton Pharmaceuticals. If investors know Eton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eton Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Earnings Share (0.26) | Revenue Per Share 1.219 | Quarterly Revenue Growth (0.24) | Return On Assets (0.12) |
The market value of Eton Pharmaceuticals is measured differently than its book value, which is the value of Eton that is recorded on the company's balance sheet. Investors also form their own opinion of Eton Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eton Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eton Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eton Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eton Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eton Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eton Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Eton Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Eton Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Eton Pharmaceuticals.
| 12/03/2022 |
| 11/22/2024 |
If you would invest 0.00 in Eton Pharmaceuticals on December 3, 2022 and sell it all today you would earn a total of 0.00 from holding Eton Pharmaceuticals or generate 0.0% return on investment in Eton Pharmaceuticals over 720 days. Eton Pharmaceuticals is related to or competes with Connect Biopharma, Acumen Pharmaceuticals, Nuvation Bio, Eledon Pharmaceuticals, Eliem Therapeutics, Inhibrx, and Celcuity LLC. Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical... More
Eton Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Eton Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Eton Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.09 | |||
| Information Ratio | 0.3579 | |||
| Maximum Drawdown | 21.89 | |||
| Value At Risk | (3.13) | |||
| Potential Upside | 7.56 |
Eton Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eton Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Eton Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Eton Pharmaceuticals historical prices to predict the future Eton Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.3021 | |||
| Jensen Alpha | 1.4 | |||
| Total Risk Alpha | 1.0 | |||
| Sortino Ratio | 0.4596 | |||
| Treynor Ratio | 1.27 |
Eton Pharmaceuticals Backtested Returns
Eton Pharmaceuticals is slightly risky given 3 months investment horizon. Eton Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.38, which denotes the company had a 0.38% return per unit of risk over the last 3 months. We were able to break down and interpolate data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.51% are justified by taking the suggested risk. Use Eton Pharmaceuticals Mean Deviation of 2.63, downside deviation of 3.09, and Coefficient Of Variation of 259.44 to evaluate company specific risk that cannot be diversified away. Eton Pharmaceuticals holds a performance score of 29 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.2, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Eton Pharmaceuticals will likely underperform. Use Eton Pharmaceuticals semi variance, and the relationship between the treynor ratio and daily balance of power , to analyze future returns on Eton Pharmaceuticals.
Auto-correlation | 0.26 |
Poor predictability
Eton Pharmaceuticals has poor predictability. Overlapping area represents the amount of predictability between Eton Pharmaceuticals time series from 3rd of December 2022 to 28th of November 2023 and 28th of November 2023 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Eton Pharmaceuticals price movement. The serial correlation of 0.26 indicates that nearly 26.0% of current Eton Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.26 | |
| Spearman Rank Test | 0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 2.9 |
Eton Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Eton Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Eton Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Eton Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Eton Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Eton Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Eton Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Eton Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Eton Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Eton Pharmaceuticals Lagged Returns
When evaluating Eton Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Eton Pharmaceuticals stock have on its future price. Eton Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Eton Pharmaceuticals autocorrelation shows the relationship between Eton Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Eton Pharmaceuticals.
Regressed Prices |
| Timeline |
Pair Trading with Eton Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eton Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eton Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Eton Stock
| 0.94 | GMAB | Genmab AS | PairCorr |
| 0.93 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.89 | VALN | Valneva SE ADR | PairCorr |
| 0.88 | LEGN | Legend Biotech Corp | PairCorr |
| 0.84 | ME | 23Andme Holding | PairCorr |
The ability to find closely correlated positions to Eton Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eton Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eton Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eton Pharmaceuticals to buy it.
The correlation of Eton Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eton Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eton Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eton Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Eton Pharmaceuticals Correlation, Eton Pharmaceuticals Volatility and Eton Pharmaceuticals Alpha and Beta module to complement your research on Eton Pharmaceuticals. To learn how to invest in Eton Stock, please use our How to Invest in Eton Pharmaceuticals guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Eton Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.